{"title":"Mechanistic Effects and Complications of Berberine on Cardiac Arrhythmias: A Systematic Review.","authors":"Shahab Masoumi, Mohammadreza Moetazedian, Samira Jafari, Saeid Heidari-Soureshjani, Catherine Mt Sherwin","doi":"10.2174/0127724328346501250404175826","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Arrhythmia is an abnormal sinus rhythm of the heartbeat, and in addition to threatening the patient's health, it may also cause fatal complications.</p><p><strong>Objectives: </strong>The present review study was investigated the effects of berberine (BBR) on cardiac arrhythmias and its possible complications.</p><p><strong>Methods: </strong>A systematic search was conducted on electronic databases such as PubMed/MEDLINE, Web of Science, Scopus, Embase, and Cochrane Library to identify relevant studies published before June 10, 2024. Inclusion criteria were defined based on the study's aim. Two reviewers performed data extraction independently to ensure accuracy and minimize bias. The data were finally extracted and analyzed.</p><p><strong>Results: </strong>Finally, 22 studies were included. BBR revealed antiarrhythmic effects through antioxidant, anti-inflammatory, and anti-apoptotic activity and improved mitochondrial function. Moreover, BBR modulated ion channels and improved electrical remodeling trough inhibited Potassium current (IK), IK1, IKr, IKs, ICa, INa, KATP channels and human ether-a-go-go related gene (hERG) and improved expression of inwardly rectifying potassium (Kir)6.2 and Kir2.1. It also increased action potential duration (APD), prolonged the effective refractory period (ERP), and reduced the frequency and complexity of ventricular premature complexes (VPC). However, it causes some cardiovascular side effects, including prolonged QT interval, bradycardia, and hypotensive effects. BBR may also lead to gastrointestinal complications, immunosuppressive effects, and interaction with concomitant drugs.</p><p><strong>Conclusion: </strong>Although BBR's cardioprotective properties have satisfactory effects on cardiac arrhythmia, it causes prolonged QT interval, bradycardia, hypotension, and cardiotoxicity. However, more clinical studies are needed to obtain more reliable results.</p>","PeriodicalId":29871,"journal":{"name":"Current Reviews in Clinical and Experimental Pharmacology","volume":" ","pages":""},"PeriodicalIF":1.3000,"publicationDate":"2025-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Reviews in Clinical and Experimental Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0127724328346501250404175826","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Arrhythmia is an abnormal sinus rhythm of the heartbeat, and in addition to threatening the patient's health, it may also cause fatal complications.
Objectives: The present review study was investigated the effects of berberine (BBR) on cardiac arrhythmias and its possible complications.
Methods: A systematic search was conducted on electronic databases such as PubMed/MEDLINE, Web of Science, Scopus, Embase, and Cochrane Library to identify relevant studies published before June 10, 2024. Inclusion criteria were defined based on the study's aim. Two reviewers performed data extraction independently to ensure accuracy and minimize bias. The data were finally extracted and analyzed.
Results: Finally, 22 studies were included. BBR revealed antiarrhythmic effects through antioxidant, anti-inflammatory, and anti-apoptotic activity and improved mitochondrial function. Moreover, BBR modulated ion channels and improved electrical remodeling trough inhibited Potassium current (IK), IK1, IKr, IKs, ICa, INa, KATP channels and human ether-a-go-go related gene (hERG) and improved expression of inwardly rectifying potassium (Kir)6.2 and Kir2.1. It also increased action potential duration (APD), prolonged the effective refractory period (ERP), and reduced the frequency and complexity of ventricular premature complexes (VPC). However, it causes some cardiovascular side effects, including prolonged QT interval, bradycardia, and hypotensive effects. BBR may also lead to gastrointestinal complications, immunosuppressive effects, and interaction with concomitant drugs.
Conclusion: Although BBR's cardioprotective properties have satisfactory effects on cardiac arrhythmia, it causes prolonged QT interval, bradycardia, hypotension, and cardiotoxicity. However, more clinical studies are needed to obtain more reliable results.
背景:心律失常是一种异常的窦性心律,除了威胁患者的健康外,还可能引起致命的并发症。目的:探讨小檗碱(BBR)对心律失常的影响及其可能的并发症。方法:系统检索PubMed/MEDLINE、Web of Science、Scopus、Embase、Cochrane Library等电子数据库,检索2024年6月10日前发表的相关研究。纳入标准是根据研究目的确定的。两名审稿人独立进行数据提取,以确保准确性并最大限度地减少偏差。最后对数据进行提取和分析。结果:最终纳入22项研究。BBR通过抗氧化、抗炎、抗凋亡和改善线粒体功能显示抗心律失常作用。此外,BBR通过调节离子通道和改善电重构抑制钾电流(IK)、IK1、IKr、IKs、ICa、INa、KATP通道和人ethera -a-go-go相关基因(hERG),提高内纠偏钾(Kir)6.2和Kir2.1的表达。增加动作电位持续时间(APD),延长有效不应期(ERP),降低室性早衰复合体(VPC)的发生频率和复杂性。然而,它会引起一些心血管副作用,包括QT间期延长、心动过缓和降压作用。BBR也可能导致胃肠道并发症、免疫抑制作用和与伴随药物的相互作用。结论:BBR对心律失常具有良好的保护作用,但可引起QT间期延长、心动过缓、低血压及心脏毒性。然而,需要更多的临床研究来获得更可靠的结果。